We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

7 hedge funds and large institutions have $845K invested in Alexion Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 693 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

99% less funds holding

Funds holding: 707 → 7 (-700)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 693

100% less funds holding in top 10

Funds holding in top 10: 77 → 0 (-77)

100% less capital invested

Capital invested by funds: $38.8B → $845K (-$38.8B)

Holders
7
Holders Change
-700
Holders Change %
-99.01%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
-77
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
693
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NICM
Neo Ivy Capital Management
New York
+$475K
2
TAIM
TD Ameritrade Investment Management
Nebraska
+$131K
3
RG
Retirement Group
California
+$9.37K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$3.74B
2
BlackRock
BlackRock
New York
-$3.21B
3
State Street
State Street
Massachusetts
-$1.84B
4
FCM
Farallon Capital Management
California
-$1.42B
5
HI
HBK Investments
Texas
-$1.21B
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
101
Ameriprise
Minnesota
– -$73.6M -400,428 Closed
Alyeska Investment Group
102
Alyeska Investment Group
Illinois
– -$73.5M -400,000 Closed
WMSA
103
Weiss Multi-Strategy Advisers
New York
– -$71.9M -391,633 Closed
AWG
104
Alpha Wave Global
New York
– -$70.6M -384,522 Closed
SRC
105
Samson Rock Capital
United Kingdom
– -$70.3M -382,552 Closed
Verition Fund Management
106
Verition Fund Management
Connecticut
– -$69.8M -380,182 Closed
National Pension Service
107
National Pension Service
South Korea
– -$69.4M -378,032 Closed
SCC
108
Spring Creek Capital
Kansas
– -$68.3M -372,000 Closed
Canada Life
109
Canada Life
Manitoba, Canada
– -$65.6M -357,334 Closed
TS
110
Twin Securities
New York
– -$65M -353,881 Closed
AC
111
Athanor Capital
New York
– -$64.4M -350,800 Closed
RPI
112
Railway Pension Investments
United Kingdom
– -$62.4M -339,693 Closed
Amundi
113
Amundi
France
– -$59.2M -322,130 Closed
BNP Paribas Financial Markets
114
BNP Paribas Financial Markets
France
– -$58.1M -316,030 Closed
State Board of Administration of Florida Retirement System
115
State Board of Administration of Florida Retirement System
Florida
– -$54.8M -298,202 Closed
GF
116
Gabelli Funds
New York
– -$54.4M -295,915 Closed
IA
117
IndexIQ Advisors
New York
– -$53.9M -293,572 Closed
ProShare Advisors
118
ProShare Advisors
Maryland
– -$53.3M -290,153 Closed
Principal Financial Group
119
Principal Financial Group
Iowa
– -$52.5M -285,699 Closed
WAM
120
Weiss Asset Management
Massachusetts
– -$50.4M -274,142 Closed
DekaBank Deutsche Girozentrale
121
DekaBank Deutsche Girozentrale
Germany
– -$47.8M -261,130 Closed
New York State Common Retirement Fund
122
New York State Common Retirement Fund
New York
– -$47.9M -260,562 Closed
New York State Teachers Retirement System (NYSTRS)
123
New York State Teachers Retirement System (NYSTRS)
New York
– -$47.5M -258,438 Closed
PMAM
124
Picton Mahoney Asset Management
Ontario, Canada
– -$46.8M -254,781 Closed
AQR Capital Management
125
AQR Capital Management
Connecticut
– -$43.8M -238,357 Closed
3 4
5
6 7

ALXN Hedge Fund Activity: Q3 2021 in Review

7 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q3 2021, worth a combined $845K — down 100% from $38.8B a quarter earlier.

Sellers outnumbered buyers: 693 funds closed out of ALXN and 1 opened new positions — a net loss of 692 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Neo Ivy Capital Management, opening a new position worth an estimated $475K. The largest seller was Vanguard Group, exiting entirely with an estimated $3.74B sold.

  • 7 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q3 2021, down from 707 in Q2 2021.
  • Funds reported $845K of Alexion Pharmaceuticals stock for Q3 2021, down 100% quarter-over-quarter.
  • 1 fund opened new Alexion Pharmaceuticals positions in Q3 2021 and 693 closed out, a net change of -692 holders.
  • The largest Alexion Pharmaceuticals buyer in Q3 2021 was Neo Ivy Capital Management, an estimated $475K added.
  • The largest Alexion Pharmaceuticals seller in Q3 2021 was Vanguard Group, an estimated $3.74B sold.

Based on aggregated 13F filings for Q3 2021.